Regulatory & Medical Community Viewpoint (2025) The leading dermatology and pharmacology reviews caution against parenteral (IV/IM) glutathione for cosmetic skin-lightening citing lack of robust evidence and significant safety concerns
Parents should watch for: Mood swings Withdrawal Big changes in sleep or appetite Teens need a care team that includes a doctor, mental health provider, and family support
Monitoring recommendations Many providers recommend baseline and periodic lab work during tirzepatide protocols
In fact, almost 20% of all people on Ozempic, in particular, experience stomach pain and discomfort at some point, according to materials published by the Food and Drug Administration (FDA)
doi: 10.3389/fphar.2026.1785129 Received 11 January 2026 Revised 18 February 2026 Accepted 02 March 2026 Published 23 March 2026 Volume 17 - 2026 Edited by Anick Brard, Montreal University, Canada Reviewed by Surendra Rajpurohit, Augusta University, United States Ayman R Fath, Minneapolis Heart Institute Foundation (MHIF), United States Updates Copyright 2026 Chen, Wang, Xie, Chen, Luo and Xu